| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 167.27▼ | 166.54▼ | 166.12▲ | 168.46▼ | 167.87▼ |
| MA10 | 167.05▼ | 166.10▲ | 166.59▼ | 167.60▼ | 174.90▼ |
| MA20 | 167.14▼ | 166.94▼ | 168.46▼ | 166.86▼ | 167.16▼ |
| MA50 | 166.42▲ | 168.33▼ | 168.15▼ | 176.13▼ | 177.52▼ |
| MA100 | 166.44▼ | 168.16▼ | 166.86▼ | 168.17▼ | 153.52▲ |
| MA200 | 168.42▼ | 166.38▲ | 171.80▼ | 177.69▼ | 111.42▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.091▼ | 0.107▲ | -0.361▼ | 0.352▲ | -0.272▼ |
| RSI | 45.845▼ | 45.375▼ | 44.452▼ | 45.765▼ | 47.034▼ |
| STOCH | 49.085 | 44.632 | 27.472 | 45.302 | 45.196 |
| WILL %R | -92.051▼ | -59.360 | -71.353 | -65.573 | -60.657 |
| CCI | -89.165 | 74.065 | -30.612 | -19.952 | -27.604 |
|
Wednesday, April 30, 2025 04:14 AM
The US Food and Drug Administration (FDA) has approved Zevaskyn (prademagene zamikeracel) gene-modified cellular sheets, also known as pz-cel, from US gene therapy developer Abeona Therapeutics ...
|
|
Monday, April 28, 2025 02:45 PM
Krystal Biotech KRYS +0.99% Get Free Report has outperformed the market over the past 5 years by 15.4% on an annualized basis producing an average annual return of 29.66%. Currently, Krystal Biotech ...
|
|
Monday, April 28, 2025 02:00 PM
Krystal Biotech (NASDAQ:KRYS) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 167.875 | 168.94 | 166.28 | 166.435 | 39,815 |
| 01/05/25 | 168.51 | 169.48 | 163.23 | 165.69 | 257,517 |
| 30/04/25 | 170.83 | 172.52 | 167.34 | 169.88 | 210,944 |
| 29/04/25 | 169.285 | 171.805 | 163.78 | 170.58 | 210,564 |
| 28/04/25 | 169.49 | 171.845 | 166.73 | 169.73 | 167,657 |
| 25/04/25 | 171.20 | 172.71 | 165.0791 | 168.06 | 171,504 |
| 24/04/25 | 166.15 | 169.305 | 164.22 | 169.12 | 249,763 |
| 23/04/25 | 174.36 | 176.73 | 165.55 | 165.80 | 232,551 |
| 22/04/25 | 164.75 | 169.41 | 163.05 | 168.80 | 271,456 |
| 21/04/25 | 166.93 | 170.50 | 161.03 | 161.91 | 291,427 |
|
|
||||
|
|
||||
|
|